Equitec Proprietary Markets’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Equitec Proprietary Markets’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,266	Closed	-$193K	–	229
2022 Q4	$193K	Buy	+17,266	New	+$167K	0.06%	78

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Equitec Proprietary Markets's OYST Position: Q1 2023 in Review

Equitec Proprietary Markets sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 17,266 shares — an estimated $193K sold.

Equitec Proprietary Markets first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $193K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Equitec Proprietary Markets reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Equitec Proprietary Markets sold 17,266 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $193K.
Equitec Proprietary Markets first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Equitec Proprietary Markets's Oyster Point Pharma, Inc. Common Stock position peaked at $193K in Q4 2022.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Equitec Proprietary Markets's 13F filing for Q1 2023, filed 28 Apr 2023.